Merrimack Pharmaceuticals

3,92 +0,51% +0,02 €
08:01:02 Uhr Frankfurt | Orderbuch | Mehr Kurse »
WKN: A2DW3Q
ISIN: US5903282094
US-Symbol: MACK
Typ: Aktie

Performance Merrimack Pharmaceuticals Aktie

  
1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 4,43 $ 4,01 $ 5,27 $ 10,25 $ 11,75 $ 83,60 $
Änderung +2,03% +12,72% -14,23% -55,90% -61,53% -94,59%

Forum zur Merrimack Pharmaceuticals Aktie

  
RichyBerlin: Ergebniserwartung verfehlt..
07.11.18
Merrimack Pharmaceuticals misses by $0.65 Nov. 7, 2018 6:55 AM ET https://seekingalpha.com/news/3406384-merrimack-​pharmaceuticals-misses-0_65?app=1 - "...Will focus program spending on Phase 1 study of MM-310, with safety update anticipated in Q1 2019, and ...
biotech1x1: News vom 24.03.2016
30.03.16
Merrimack Announces Inclusion of ONIVYDE® (irinotecan liposome injection) as a Category 1 Treatment Option in the 2016 NCCN Guidelines for Pancreatic Adenocarcinoma https://beta.finance.yahoo.com/news/merrimack-​announces-inclusion-onivyde-irinotecan-...

Analysen

  
Kaufen Halten Verkaufen
Analysten 0 0 0
Markt-Lotsen 0 0 0

Aktie & Unternehmen

  
Branche Pharmazeutik
Herkunft USA
Website www.merrimack.com
Aktienanzahl 13,3 Mio. (Stand: 13.09.18)
Marktkap. 52,3 Mio. €

Dividenden & Splits

  
06.09.17 Reverse Split 10:1
30.05.17 Dividende   10,00 EUR

Ähnliche Aktien

  
Name
last
change_rel
 
Achieve Life Science 1,54 € -2,53%
KalVista Pharmaceuticals 16,33 € +3,68%
Catabasis Pharmaceuticals 0,528 € +0,19%
Editas Medicine 25,20 € +1,61%
Nantkwest 1,96 € +1,55%